United States · FDA National Drug Code directory
POSLUMA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69932-002_67cbcafa-00b3-41fd-986d-1159706273f3
- Product NDC
- 69932-002
- Form
- INJECTION
- Composition / generic term
- flotufolastat F-18
- Labeler
- Blue Earth Diagnostics
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230525
- Source listing expiry
- 20271231
Source-listed ingredients
- FLOTUFOLASTAT F-18 — 158 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 mL in 1 VIAL, MULTI-DOSE (69932-002-50) · 69932-002-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →